Rick Strassman and the Spirit Molecule: DMT Research That Changed Everything | Self Growth Videos

In 1990, Rick Strassman received approval from the FDA and the DEA to administer DMT to human volunteers at the University of New Mexico. It was the first federally sanctioned psychedelic research in the United States in nearly two decades — a period during which the entire field had been effectively shut down following the political backlash of the 1970s.

What he found over the next five years changed his understanding of consciousness, of science, and of what it means to be human. His book DMT: The Spirit Molecule, published in 2000, introduced millions of people to a substance their own bodies were already producing.

The Man Behind the Research

Rick Strassman is not the obvious candidate for a psychedelic researcher. He received his medical degree from Stanford and completed a psychiatric residency at UC Davis. He was ordained as a rabbi in the Jewish Renewal movement. He spent years as a serious meditator before concluding that contemplative practice, however valuable, wasn’t generating the kind of extreme states being described in mystical literature.

The question he kept returning to: what is the biological basis for mystical experience? The pineal gland had long been associated with spiritual traditions across cultures — Descartes called it the seat of the soul — and there were theoretical reasons to think it might produce endogenous DMT. Strassman wanted to study what DMT actually did to people in a controlled setting.

Getting that approval took years of regulatory navigation that would test anyone’s patience. The research landscape after the scheduling of psychedelics in the 1970s was essentially frozen. Strassman’s persistence in working through the DEA, FDA, and his own university administration makes his research accomplishment as much bureaucratic as scientific.

The Study Design

Strassman’s protocol was methodical by design. He needed it to be — any deviation from rigorous procedure would risk the first federally approved psychedelic research approval in a generation.

Sixty volunteers participated across 400 DMT sessions. Participants were psychologically screened, experienced with psychedelics (a criterion Strassman considered important for the ability to report experiences coherently), and administered DMT intravenously in a controlled hospital setting. Dosages ranged from low (threshold effects) to high (0.4 mg/kg — a full psychedelic dose).

The research nurse who assisted throughout the study became one of the most important elements of the work. Her clinical steadiness and open acceptance of whatever participants reported — however strange — created the safety that allowed genuine reporting.

What the Subjects Reported

This is where the research becomes genuinely difficult to categorize.

Strassman had expected reports of vivid visual hallucinations. What he got, repeatedly and across participants with no prior communication about each other’s experiences, was something qualitatively different: contact with autonomous, intelligent non-human entities in a space that felt more real than ordinary reality.

The reports were remarkably consistent. Participants described:

  • Being transported to a place that felt more real, not less, than waking life
  • Encountering beings — described as insectoid, reptilian, elf-like, or angelic depending on the individual’s cultural framework — that were purposeful and communicative
  • The beings appearing to expect them, as if the visit was anticipated
  • Communication that wasn’t verbal but felt direct, meaningful, and real
  • A sense of being examined, worked on, or shown something important
  • Coming back feeling they had witnessed something that fundamentally couldn’t be classified as a dream or hallucination

Strassman had a prior framework for this. He had studied theophanies — divine encounters — in Biblical and rabbinic literature. The DMT reports bore a striking structural resemblance to accounts in prophetic texts of being visited by messengers, entering divine spaces, and receiving information from non-human intelligences.

The Consciousness Problem

The standard neuroscientific interpretation would classify these reports as hallucinations — internally generated imagery produced by an overstimulated brain. But Strassman found this explanation increasingly inadequate as the studies progressed.

Hallucinations, by definition, are individual and internally generated. What Strassman’s subjects were reporting was cross-validated — the same types of beings, the same spatial quality, the same sense of heightened reality — across people who hadn’t compared notes. Random internally generated imagery doesn’t produce this kind of consistency.

By the end of the study period, Strassman had moved toward what he calls a “receiver model” of consciousness: the possibility that the brain, rather than generating consciousness from scratch, acts as a receiver and filter — and that DMT temporarily removes or loosens that filter, allowing something external to break through. This isn’t a position he holds dogmatically, but it’s one he believes the data makes more defensible than simple dismissal.

You can explore this framework more fully in our piece on the consciousness receiver theory.

The Endogenous DMT Question

One of the most significant contributions of Strassman’s work — and one that continues to drive research today — is the theoretical framework around endogenous DMT production.

Strassman proposed that the human pineal gland might produce DMT under certain conditions, including near-death experiences, intense meditation, and the threshold between sleep and waking. This hypothesis remains controversial. The evidence for DMT production specifically in the pineal gland is limited; DMT has been conclusively identified in human blood, urine, and lung tissue, but the pineal source hypothesis depends on indirect evidence.

What is not controversial: DMT is endogenous. The human body produces it. The brain has specialized receptors for it. Whatever its source, it’s not a foreign invader. The question of why the body produces a compound that produces some of the most profound altered states known — and what function that production serves — is genuinely open. Strassman’s pineal hypothesis gave the research community a falsifiable target that has driven significant subsequent work.

Read more about the endogenous DMT evidence in our piece on the pineal gland and endogenous DMT.

After the Research

Strassman ended his DMT research in 1995, citing his discomfort with some of what he was observing — specifically, the number of participants reporting experiences that seemed to involve genuine contact with external intelligences rather than internal projections. This was a scientist’s honest confrontation with data that didn’t fit his existing frameworks, and he deserves credit for saying so openly rather than interpreting everything through a prior narrative.

He has continued writing and speaking on these themes. His subsequent books — Inner Paths to Outer Space (co-authored) and DMT and the Soul of Prophecy — develop his investigation into the relationship between DMT experiences and prophetic and mystical literature. He also contributed to the founding of the Cottonwood Research Foundation, which continues psychedelic research with a particular focus on endogenous psychedelics.

The documentary The Spirit Molecule, released in 2010, brought his research to a much wider audience and played a significant role in the popular reawakening of interest in DMT and plant medicine that has continued ever since.

The Strassman Legacy

Rick Strassman didn’t discover DMT. The compound was first synthesized by Canadian chemist Richard Manske in 1931 and its psychoactive properties were identified by Hungarian chemist and psychiatrist Stephen Szára in 1956. What Strassman did was bring it into a rigorous clinical setting at a moment when the entire field was dormant, produce careful documentation of its effects, and have the intellectual honesty to publish what he found — including the parts that didn’t fit the conventional hallucinogen model.

The wave of DMT research that has followed — at Johns Hopkins, at Imperial College, at the University of New Mexico — builds directly on the methodological and conceptual groundwork his study established.

For the complete picture of what DMT does and what the science shows, start with our DMT complete guide.


Related:

Subscribe YouTube Suggest